Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Short guide to identifying dividend ETFs with the absolute lowest fees and what to consider beyond price.
27,457 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
A meme-focused token from MemeCore dropped roughly 70%, sending its market cap below $1 billion and triggering renewe...
Ford shifts AI strategy by adding 350 veteran engineers to steer its tools, citing early limits of automation and a r...
Chipotle and Microsoft have taken divergent paths in 2026. CMG rides restaurant-demand strength while MSFT grapples w...
Shiba Inu burned roughly 110 million SHIB on July 8, the largest in six months, yet SHIB continues to slide as broade...
Oracle shares slide as Larry Ellison funds a bid to steer a $110 billion media empire, triggering regulatory hurdles ...
Airbnb embraces AI as a growth engine, with Chesky warning competitors to adapt quickly or risk falling behind, as th...
When a CEO puts real money behind his own company’s stock, investors sit up and take notice. This article breaks down...
Bitcoin prices retreat toward $60,000 while the Fear & Greed Index hits Extreme Fear. Here’s how traders assess risk,...
A Senate staff brief on the ROAD to Housing Act flags design flaws and local zoning reliance, signaling lenders and b...
CoreWeave surged after its IPO, then pulled back dramatically. This guide explains what happened, what the company do...
PI traders faced renewed selling pressure this week, driving PI below key thresholds. The market now tests 0.15 suppo...